查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828198

2025年外泌体诊断与治疗全球市场报告

Exosome Diagnostic And Therapeutic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，外泌体诊断和治疗市场呈指数级增长，从2024年的4.7亿美元增长到2025年的6亿美元，复合年增长率为29.3%。预测期内的成长归因于生物学研究的进步、精准医疗的兴起、生物医学影像、癌症研究和肿瘤学的创新以及医疗保健产业的投资。

预计未来几年外泌体诊断和治疗市场规模将呈指数级增长，到2029年将达到16.2亿美元，年复合成长率（CAGR）为28.0%。预测期内的成长可归因于不断扩展的临床应用、与数位健康技术的整合、有利的法规环境、基因编辑和RNA疗法，以及免疫肿瘤学日益重要的作用。预测期内的主要趋势包括基于外泌体的药物发现、仿生外泌体工程、外泌体产品的商业化、外泌体负载的治疗性药物以及用于癌症筛检的液态切片。

外泌体诊断与治疗涉及利用外泌体（细胞产生的细胞外小颗粒）进行诊断和治疗。外泌体在治疗上被用作递送标靶药物的手段，尤其是在再生医学领域。

外泌体诊断和治疗市场的关键产品是仪器、软体、试剂和套件。仪器是指用于准确、精确地执行活动和实验的设备。这些产品在诊断和治疗领域有着广泛的应用，并提供给各种最终用户，包括学术和研究机构、製药和生物技术公司、医院和诊所。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供外泌体诊断和治疗市场统计数据，包括全球市场规模、区域份额、外泌体诊断和治疗市场份额的竞争对手、详细的外泌体诊断和治疗细分市场、市场趋势和商业机会，以及您在外泌体诊断和治疗行业取得成功所需的数据。这份外泌体诊断和治疗市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面观点所需的一切。

我们对该市场未来五年28.0%的成长率预测与先前的预测一致。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自瑞士和韩国等主要地区的超速离心管和奈米颗粒追踪分析仪征收关税直接影响美国，从而可能减缓精准医疗的进展，并增加新型生物标记研究的成本。这种影响可能会透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，更广泛地显现出来。

外泌体诊断和治疗市场的预期成长主要受到慢性病盛行率上升的强烈推动。慢性病持续超过三个月，且往往会随着时间的推移而恶化，是全球面临的重大健康问题。外泌体既可用于诊断，也可用于治疗，已成为癌症领域极具前景的生物标记物，能够实现更灵敏的疾病监测，并促进个人化医疗的普及。根据美国国家生物技术资讯中心 (NCBI) 于 2023 年 1 月发布的预测，到 2050 年，全球慢性病患者人数将达到 1.4266 亿。这项统计数据凸显了慢性病盛行率上昇在推动外泌体诊断和治疗市场发展的关键作用。

老年人口的成长进一步加速了外泌体诊断和治疗市场的成长轨迹。 「老年人口」指的是65岁及以上的人。由于外泌体为诊断和治疗与老龄化相关的疾病提供了宝贵的工具，因此人口结构的扩张极大地促进了对外泌体诊断和治疗的需求。根据世界卫生组织（WHO）于2022年10月发布的报告，人口结构正在发生重大变化，预计到2030年，全球整体六分之一的人口将达到60岁或以上。到2050年，预计全球将有21亿人达到60岁或以上。这项人口结构变化证实，老年人口的成长将对外泌体诊断和治疗市场的成长产生重大影响。

主要企业正在积极开发创新产品，例如样品纯化系统，以扩大基本客群、增加销售并推动收益成长。样品纯化系统包含一系列旨在从各种样品类型（包括 DNA、RNA、蛋白质和其他生物分子）中去除杂质和污染物的製程和技术。例如，2023 年 2 月，美国着名生物技术公司 Biological Dynamics 推出了 ExoVita，这是一个专为早期疾病监测和多种应用而设计的外泌体分离平台。作为该平台的一部分，ExoVita 胰腺检测证明了使用取得专利的ExoVerita 设备血液外泌体样本识别特定外泌体蛋白指标并检测 1 期和 2 期胰腺导管腺癌 (PDAC) 的能力。该公司正在透过 ExoLuminate 註册试验 (NCT05625529) 积极检验这些发现，该试验正在招募高风险 PDAC 患者以评估该测试的临床价值。

外泌体诊断和治疗市场的主要企业正在采用策略联盟方式来增强外泌体纯化过程。策略伙伴关係是指公司利用彼此的优势和资源，实现互利共赢的伙伴关係。一个值得注意的例子是美国着名生技公司 Cytiva 与另一家美国生技公司 RoosterBio 之间的合作。该合作于 2023 年 10 月宣布，旨在改进外泌体纯化过程，这是目前阻碍有前景的基因疗法和其他创新治疗方法广泛使用的瓶颈。透过结合两家公司的优势，此次合作旨在解决限制外泌体治疗应用的关键挑战，特别是作为基因疗法和生技药品的载体。预期结果是提高大规模外泌体製造能力。

2023年6月，英国生技公司Evox Therapeutics Ltd.以未揭露的金额收购了Codiak Biosciences的engEx-AAV技术平台。此次收购旨在利用engEx-AAV技术改进外泌体介导的递送系统，并加速创新基因疗法和基因组编辑技术的进步。这项策略决策旨在增强Evox Therapeutics在有效基因药物开发方面的能力。 Kodiak Biosciences是一家专注于发现基于外泌体的疗法的美国生物製药公司。

外泌体诊断与治疗市场的主要企业包括 Thermo Fisher Scientific Inc.、Lonza Group AG、Bio-Techne Corp.、Miltenyi Biotec GmBH、Malvern Instruments Inc.、BioVision Inc.、System Biosciences LLC、Evox Therapeutics Ltd.、ExCoBio Inc.、BioCatSombH、Nnos. Inc.、Aethlon Medical Inc.、Codiak BioSciences Inc.、NX Pharmagen Inc.、Exiqon A/S、Aegle Therapeutic Corporation、AMS Biotechnology Ltd.、Cell Guidance Systems、Ciloa、Sienna Diagnostics、Sistemic Inc.、Theoria Science 和 Mantra Bio Inc.

2024年外泌体诊断与治疗市场最大的地区是北美。预计亚太地区将成为预测期内成长最快的地区。外泌体诊断和治疗市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

外泌体诊断和治疗市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、义大利、西班牙和加拿大。

外泌体诊断和治疗市场由提供基因组定序、EXOME定序、重定序和标靶定序等服务的营业单位所获得的收益所构成。市场价值包括服务供应商销售的或包含在其服务产品中的任何相关产品的价值。外泌体诊断和治疗市场还包括用于提供外泌体药物输送服务的外泌体检测试剂盒、外泌体流式细胞技术套件和蛋白质生物标记检测套件的销售。该市场的价值是指“出厂价”，即产品製造商或创造者销售的产品价值，无论是销售给其他营业单位（包括下游製造商、经销商、分销商和零售商）或直接销售给最终客户。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球外泌体诊断与治疗：PESTEL分析（政治、社会、技术、环境、法律、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球外泌体诊断与治疗市场：成长率分析
  • 全球外泌体诊断与治疗市场表现：规模与成长，2019-2024
  • 全球外泌体诊断与治疗市场预测：规模与成长，2024-2029年，2034年
  • 全球外泌体诊断与治疗：总目标市场（TAM）

第六章 市场细分

  • 全球外泌体诊断与治疗市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 软体
  • 试剂和套件
  • 全球外泌体诊断与治疗市场：按应用、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断
  • 治疗
  • 全球外泌体诊断与治疗市场：依最终使用者、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究机构
  • 製药和生物技术公司
  • 医院和诊所
  • 其他最终用户
  • 全球外泌体诊断与治疗市场：按设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 外泌体分离系统
  • 特性分析设备
  • 分析器
  • 全球外泌体诊断与治疗市场：按软体类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 数据分析软体
  • 外泌体分析软体
  • 实验室管理软体
  • 全球外泌体诊断与治疗市场：按试剂和套件（按类型）细分、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 隔离套件
  • 表征试剂
  • 检测试剂套件

第七章 区域和国家分析

  • 全球外泌体诊断与治疗市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球外泌体诊断和治疗市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 外泌体诊断与治疗市场：竞争格局
  • 外泌体诊断与治疗市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
    • Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • BioVision Inc.
  • System Biosciences LLC
  • Evox Therapeutics Ltd.
  • ExCoBio Inc.
  • BioCat GmbH
  • NanoSomix Inc.
  • Exosome Diagnostics Inc.
  • Capricor Therapeutics Inc.
  • Aethlon Medical Inc.
  • Codiak BioSciences Inc.
  • NX Pharmagen Inc.
  • Exiqon A/S
  • Aegle Therapeutics Corporation
  • AMS Biotechnology Ltd.
  • Cell Guidance Systems

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年外泌体诊断与治疗市场：提供新机会的国家
  • 2029年外泌体诊断与治疗市场：细分领域带来新机会
  • 外泌体诊断与治疗市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24910u

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.47 billion in 2024 to $0.6 billion in 2025 at a compound annual growth rate (CAGR) of 29.3%. The growth in the historic period can be attributed to biological research advancements, the emergence of precision medicine, biomedical imaging innovations, cancer research and oncology, and healthcare industry investments.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to growing clinical applications, integration with digital health technologies, supportive regulatory environment, gene editing and RNA therapeutics, and expanded role in immuno-oncology. Major trends in the forecast period include exosome-based drug discovery, biomimetic exosome engineering, commercialization of exosome products, exosome-loaded therapeutic cargo, and liquid biopsy for cancer screening.

The forecast of 28.0% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on ultracentrifugation tubes and nanoparticle tracking analyzers, sourced from key regions such as Switzerland and South Korea, which could lead to slowed advancements in precision medicine and higher costs for novel biomarker research.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

The upward trajectory of the exosome diagnostic and therapeutic market is further fueled by the increasing size of the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older, often in the later stages of life. This demographic expansion contributes significantly to the demand for exosome diagnostics and therapeutics, as exosomes serve as valuable tools for diagnosing and addressing age-related conditions. Notably, a report from the World Health Organization (WHO) in October 2022 indicates a profound demographic shift, with one in six individuals projected to be 60 or older by 2030 globally. By 2050, an estimated 2.1 billion people worldwide will be 60 years old or older. This demographic shift underscores the substantial impact of the rising geriatric population on driving the growth of the exosome diagnostic and therapeutic market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

Major players in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. A noteworthy example is the collaboration between Cytiva, a prominent US-based biotechnology company, and RoosterBio Inc., also a US-based biotechnology company. Announced in October 2023, this partnership aims to improve the exosome purification process, a current bottleneck hindering the widespread adoption of promising gene therapies and other innovative modalities. By combining the strengths of both entities, the collaboration seeks to address a significant challenge limiting the use of exosomes in therapeutic applications, particularly as carriers for gene therapies and biologics. The envisioned outcome is the advancement of large-scale manufacturing capabilities for exosomes.

In June 2023, Evox Therapeutics Ltd., a biotechnology company based in the UK, acquired the engEx-AAV technology platform from Codiak Biosciences for an undisclosed sum. The purpose of this acquisition is to utilize the engEx-AAV technology to improve exosome-mediated delivery systems, facilitating the advancement of innovative gene therapies and genome editors. This strategic decision aims to bolster Evox Therapeutics' capabilities in developing effective genetic medicines. Codiak Biosciences is a biopharmaceutical company located in the US that focuses on creating exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market include Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Software; Reagents And Kits
  • 2) By Application: Diagnostics; Therapeutic
  • 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
  • Subsegments:
  • 1) By Instruments: Exosome Isolation Systems; Characterization Instruments; Analysis Devices
  • 2) By Software: Data Analysis Software; Exosome Profiling Software; Laboratory Management Software
  • 3) By Reagents And KITS: Isolation KITS; Characterization Reagents; Assay KITS
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.; BioVision Inc.; System Biosciences LLC; Evox Therapeutics Ltd.; ExCoBio Inc.; BioCat GmbH; NanoSomix Inc.; Exosome Diagnostics Inc.; Capricor Therapeutic Inc.; Aethlon Medical Inc.; Codiak BioSciences Inc.; NX Pharmagen Inc.; Exiqon A/S; Aegle Therapeutic Corporation; AMS Biotechnology Ltd.; Cell Guidance Systems; Ciloa; Sienna Diagnostics; Sistemic Inc.; Theoria Science; Mantra Bio Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Diagnostic And Therapeutic Market Characteristics

3. Exosome Diagnostic And Therapeutic Market Trends And Strategies

4. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Exosome Diagnostic And Therapeutic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Exosome Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Exosome Diagnostic And Therapeutic Market Growth Rate Analysis
  • 5.4. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Exosome Diagnostic And Therapeutic Total Addressable Market (TAM)

6. Exosome Diagnostic And Therapeutic Market Segmentation

  • 6.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Software
  • Reagents And Kits
  • 6.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Therapeutic
  • 6.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Clinics
  • Other End Users
  • 6.4. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exosome Isolation Systems
  • Characterization Instruments
  • Analysis Devices
  • 6.5. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Exosome Profiling Software
  • Laboratory Management Software
  • 6.6. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Reagents And KITS, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Isolation KITS
  • Characterization Reagents
  • Assay KITS

7. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

  • 7.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Diagnostic And Therapeutic Market

  • 8.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Diagnostic And Therapeutic Market

  • 9.1. China Exosome Diagnostic And Therapeutic Market Overview
  • 9.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Diagnostic And Therapeutic Market

  • 10.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Diagnostic And Therapeutic Market

  • 11.1. Japan Exosome Diagnostic And Therapeutic Market Overview
  • 11.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Diagnostic And Therapeutic Market

  • 12.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Diagnostic And Therapeutic Market

  • 13.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Diagnostic And Therapeutic Market

  • 14.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
  • 14.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Diagnostic And Therapeutic Market

  • 15.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
  • 15.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Diagnostic And Therapeutic Market

  • 16.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Diagnostic And Therapeutic Market

  • 17.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Diagnostic And Therapeutic Market

  • 18.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Diagnostic And Therapeutic Market

  • 19.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Diagnostic And Therapeutic Market

  • 20.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Diagnostic And Therapeutic Market

  • 21.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
  • 21.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Diagnostic And Therapeutic Market

  • 22.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Diagnostic And Therapeutic Market

  • 23.1. North America Exosome Diagnostic And Therapeutic Market Overview
  • 23.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Diagnostic And Therapeutic Market

  • 24.1. USA Exosome Diagnostic And Therapeutic Market Overview
  • 24.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Diagnostic And Therapeutic Market

  • 25.1. Canada Exosome Diagnostic And Therapeutic Market Overview
  • 25.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Diagnostic And Therapeutic Market

  • 26.1. South America Exosome Diagnostic And Therapeutic Market Overview
  • 26.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Diagnostic And Therapeutic Market

  • 27.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Diagnostic And Therapeutic Market

  • 28.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
  • 28.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Diagnostic And Therapeutic Market

  • 29.1. Africa Exosome Diagnostic And Therapeutic Market Overview
  • 29.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

  • 30.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape
  • 30.2. Exosome Diagnostic And Therapeutic Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

  • 31.1. BioVision Inc.
  • 31.2. System Biosciences LLC
  • 31.3. Evox Therapeutics Ltd.
  • 31.4. ExCoBio Inc.
  • 31.5. BioCat GmbH
  • 31.6. NanoSomix Inc.
  • 31.7. Exosome Diagnostics Inc.
  • 31.8. Capricor Therapeutics Inc.
  • 31.9. Aethlon Medical Inc.
  • 31.10. Codiak BioSciences Inc.
  • 31.11. NX Pharmagen Inc.
  • 31.12. Exiqon A/S
  • 31.13. Aegle Therapeutics Corporation
  • 31.14. AMS Biotechnology Ltd.
  • 31.15. Cell Guidance Systems

32. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

34. Recent Developments In The Exosome Diagnostic And Therapeutic Market

35. Exosome Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

  • 35.1 Exosome Diagnostic And Therapeutic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Exosome Diagnostic And Therapeutic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Exosome Diagnostic And Therapeutic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer